Literature DB >> 27439965

Complex Transfusion Issues in Pediatric Hematopoietic Stem Cell Transplantation.

Jennifer Webb1, Allistair Abraham2.   

Abstract

Advances in the fields of pediatric transfusion medicine and hematopoietic stem cell transplant have resulted in improved outcomes but also present new questions for research. The diagnostic capabilities involved in transfusion medicine have improved in recent times, now including methods for determination of red blood cell minor antigens, detection of anti-human leukocyte antigen antibodies, and noninvasive iron quantification. At the same time, transplants are being performed for more indications including nonmalignant disease and with less intense conditioning regimens that allow some recipient blood cells to persist after transplant. We are therefore faced with new opportunities to understand the implications of transfusion medicine testing and to develop data-driven guidelines relevant to the current-day approach to transfusion and transplantation.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  ABO incompatibility; Hematopoietic stem cell transplant; Pediatric; Transfusion

Mesh:

Substances:

Year:  2016        PMID: 27439965     DOI: 10.1016/j.tmrv.2016.06.002

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  3 in total

Review 1.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

Review 2.  Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease.

Authors:  Yan Zheng; Stella T Chou
Journal:  Clin Lab Med       Date:  2020-12-24       Impact factor: 1.935

3.  CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model.

Authors:  Prabitha Natarajan; Dong Liu; Seema R Patel; Manjula Santhanakrishnan; Daniel Beitler; Jingchun Liu; David R Gibb; Justine S Liepkalns; David J Madrid; Stephanie C Eisenbarth; Sean R Stowell; Jeanne E Hendrickson
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.